CARLY REID: Open Payments
NPI 1356097687 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,189 in 94 payments from 19 companies in 2025. Trend: 2023 $279 · 2024 $1,397 · 2025 $2,189
Food & beverage: $1,846Education: $343
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 32 | $935 |
| ABBVIE INC. | 13 | $202 |
| Regeneron Healthcare Solutions, Inc. | 5 | $195 |
| UCB, Inc. | 12 | $161 |
| Lilly USA, LLC | 6 | $122 |
| GENZYME CORPORATION | 4 | $91 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| Galderma Laboratories, L.P. | 4 | $89 |
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| Amgen Inc. | 2 | $38 |
Products named: TREMFYA, DUPIXENT, Bimzelx, RINVOQ, EBGLYSS, SKYRIZI, NEMLUVIO, COSENTYX.
Industry payments across UT — which companies pay providers there.
